All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

Article

Equipment and Processing Report

October 19, 2011

Equipment and Processing Report

Equipment and Processing Report-10-19-2011
Volume0
Issue 0

October 2011 Editor's Picks: Products from Edwards and Moyno

Author(s):

Pharmaceutical Technology Editors

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the October 2011 edition from Edwards and Moyno.

Edwards
Dry pump includes tapered, variable-pitch screw technology

The CXS dry vacuum pumps from Edwards incorporate tapered, variable-pitch screw technology that enables gradual compression along the length of the rotor. As a result, users can control the temperature better than they can with other dry-pump technology.

Unlike other marketed pumps that use screw technology, the CXS pumps do not have a cantilever rotor design, and they do not have an end compression plate. The pumps thus do not compact any material when they cool down and have excellent solids handling. These characteristics help to prevent cold seizures and make it easy to restart with solids still in the pump.

The pump’s rotors are designed to not match each other exactly. When one rotor is damaged, a user thus can replace it without having to replace both. The CXS pump also monitors its own temperature and does not begin processing until it is ready. When the pump is not needed, it runs at a lower speed and power level to save energy. The pump is designed to require an exceptionally low level of energy for operation.

Moyno
Positive-displacement pump facilitates maintenance

Moyno’s Moyno 1000 close-coupled positive-displacement pump is designed to provide more versatility and performance advantages than other types of positive-displacement pumps. The pump’s two-piece drive shaft facilitates assembly, maintenance, and access to the mechanical seal. The drive-shaft configuration eliminates the need to disassemble the pump completely when servicing the mechanical seal. In addition, the machine’s pin-type universal joint is sealed and lubricated, which lengthens the device’s service life and reduces maintenance requirements.

The Moyno 1000 pump provides smooth, nonpulsating flow at rates from 0.38 to 320 gpm. The unit is also designed for low-shear pumping action and provides pressures as high as 350 psi. The pump can handle viscosities as great as 1,000,000 cps and fluid temperatures as high as 350 °F. The unit’s compact configuration is appropriate for areas with limited space. The pump can perform applications that involve shear-sensitive chemicals, pharmaceutical pastes, and lotions.

Articles in this issue

Scaling Up a Tableting Process
Steps for Reducing Glass Delamination
Moyno-1000web-743894-1408613178642.jpg
October 2011 Editor's Picks: Products from Edwards and Moyno
Isolated Robotics: The Future of Aseptic Operations

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
 Benjamin McLeod and Sebastian Lykke Skafte Andersen go behind the headlines to examine the motivations behind recent M&A activity, tariff responses, and more.
Tariffs & Trade Policy: Results of a Bio/Pharma Peer Survey
Related Content
Advertisement
Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs | Image Credit: © Sundry Photography - stock.adobe.com
August 27th 2025

Gilead Sciences’ HIV PrEP Injectable Approved by European Commission

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 27th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
B. Braun - german medical technology company, Czech branch | Image Credit: © Solarisys - stock.adobe.com
August 27th 2025

B. Braun Medical Voluntarily Recalls Two Injections, Citing Presence of Particulate Matter

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 27th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 27th 2025

Johnson & Johnson Invests $2 Billion into North Carolina Facility

Susan Haigney
Human urinary system kidneys with bladder anatomy on doctor hands. Treatment of urinary tract infections, urinary incontinence or urinary retention. Urology concept. | Image Credit: © Orawan - stock.adobe.com
August 27th 2025

Iterum's UTI Drug Launches as First Commercial Oral Penem Antibiotic in US

Patrick Lavery
Related Content
Advertisement
Feb 19, 2020 Foster City / CA / USA - Gilead sign at their headquarters in Silicon Valley; Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs | Image Credit: © Sundry Photography - stock.adobe.com
August 27th 2025

Gilead Sciences’ HIV PrEP Injectable Approved by European Commission

Patrick Lavery
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 27th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
B. Braun - german medical technology company, Czech branch | Image Credit: © Solarisys - stock.adobe.com
August 27th 2025

B. Braun Medical Voluntarily Recalls Two Injections, Citing Presence of Particulate Matter

Patrick Lavery
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 27th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 27th 2025

Johnson & Johnson Invests $2 Billion into North Carolina Facility

Susan Haigney
Human urinary system kidneys with bladder anatomy on doctor hands. Treatment of urinary tract infections, urinary incontinence or urinary retention. Urology concept. | Image Credit: © Orawan - stock.adobe.com
August 27th 2025

Iterum's UTI Drug Launches as First Commercial Oral Penem Antibiotic in US

Patrick Lavery
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.